Northwestern Mutual Wealth Management’s RenovoRx RNXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.1K Sell
74,596
-24,864
-25% -$22.6K ﹤0.01% 2392
2026
Q1
$100K Buy
99,460
+24,844
+33% +$24K ﹤0.01% 2172
2025
Q4
$62.7K Buy
74,616
+20
+0% +$20 ﹤0.01% 2310
2025
Q3
$94.7K Hold
74,596
﹤0.01% 2067
2025
Q2
$98.1K Buy
+74,596
New +$85K ﹤0.01% 2003

Other funds holding RNXT

Northwestern Mutual Wealth Management's RNXT Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its RenovoRx (RNXT) stake by 25% in Q2 2026, selling an estimated $22.6K and leaving 74,596 shares worth $73.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

Northwestern Mutual Wealth Management first reported a position in RNXT in Q2 2025 and has held it in 5 quarters since. The position peaked at $100K in Q1 2026. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • Northwestern Mutual Wealth Management held 74,596 shares of RenovoRx worth $73.1K as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 24,864 RenovoRx shares in Q2 2026, an estimated $22.6K.
  • RenovoRx made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2392 holding.
  • Northwestern Mutual Wealth Management first reported a position in RenovoRx in Q2 2025 and has held it in 5 quarters since.
  • Northwestern Mutual Wealth Management's RenovoRx position peaked at $100K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.